PK / Phase I Unit

Specialized PK / Phase I Unit for Early-Phase Clinical Trials

Our PK / Phase I Unit is specifically designed to support early-phase clinical trials, including pharmacokinetic (PK) studies, first-in-human protocols, and dose-escalation research.

The unit provides a controlled environment for intensive monitoring, precise sample collection, and protocol-driven execution.

PATIENT MONITORING & SETUP

Designed for patient continuous observation, the unit supports intensive monitoring required in early-phase trials.

The layout allows for efficient patient flow, comfort, and close clinical supervision during study procedures.

PK SAMPLING CAPABILITIES

Equipped to perform precise pharmacokinetic (PK) sampling at multiple time points, ensuring accurate and reliable data collection in accordance with protocol requirements.

Our workflows are optimized for timing accuracy, sample integrity, and seamless coordination with laboratory processing.

OPERATIONAL CAPABILITIES

- Support for first-in-human and dose-escalation studies

- Intensive patient monitoring protocols

- High-frequency blood sampling execution

- Close coordination with on-site laboratory processing

- Efficient study flow and staff coordination

SAFETY & COMPLIANCE

- GCP-compliant procedures

- Strict adherence to protocol timelines

- Patient safety and monitoring prioritized

- Controlled and supervised clinical environment

PERFORMANCE EDGE

Our Phase I capabilities enable sponsors to conduct complex early-phase studies with confidence, ensuring accurate data collection, patient safety, and operational efficiency.